Compass Therapeutics (CMPX) Treasury Shares (2018 - 2020)

Compass Therapeutics has reported Treasury Shares for 9 years, with the latest figure at $1.6 million in Q1 2026.

• Quarterly Treasury Shares fell 45.43% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 45.43% YoY) and the FY2025 annual result came in at $1.0 million, down 72.7% from the prior year.
• Treasury Shares improved to $1.6 million in Q1 2026 per CMPX's latest filing, from $1.0 million in the prior quarter.
• Over five years, Treasury Shares peaked at $3.8 million in Q4 2024 and troughed at $132000.0 in Q1 2023.
• A 5-year average of $2.0 million and a median of $1.6 million in 2026 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares tumbled 89.0% in 2023, then soared 2677.27% in 2024.
• Over 5 years, Treasury Shares stood at $900000.0 in 2022, then soared by 66.67% to $1.5 million in 2023, then soared by 151.07% to $3.8 million in 2024, then slumped by 72.7% to $1.0 million in 2025, then jumped by 56.23% to $1.6 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.6 million, $1.0 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.